BR102014003033B8 - processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta - Google Patents

processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta

Info

Publication number
BR102014003033B8
BR102014003033B8 BR102014003033A BR102014003033A BR102014003033B8 BR 102014003033 B8 BR102014003033 B8 BR 102014003033B8 BR 102014003033 A BR102014003033 A BR 102014003033A BR 102014003033 A BR102014003033 A BR 102014003033A BR 102014003033 B8 BR102014003033 B8 BR 102014003033B8
Authority
BR
Brazil
Prior art keywords
origin
unknown
quality control
tumor samples
control process
Prior art date
Application number
BR102014003033A
Other languages
English (en)
Other versions
BR102014003033B1 (pt
BR102014003033A2 (pt
Inventor
Lopes Carvalho Andre
Feres De Souza Bruno
Ribeiro Viana Cristiano
Scapulatempo Neto Cristovam
Mavignier Carcano Flavio
Tadeu Dos Santos Marcos
De Oliveira Vidal Ramon
Original Assignee
Fleury S/A
Hospital Do Cancer De Barretos Fund Pio Xii
Tadeu Dos Santos Marcos
De Oliveira Vidal Ramon
Univ Federal Do Maranhao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fleury S/A, Hospital Do Cancer De Barretos Fund Pio Xii, Tadeu Dos Santos Marcos, De Oliveira Vidal Ramon, Univ Federal Do Maranhao filed Critical Fleury S/A
Priority to BR102014003033A priority Critical patent/BR102014003033B8/pt
Priority to EP14882107.7A priority patent/EP3102695A4/en
Priority to US15/117,023 priority patent/US20170183738A1/en
Priority to CA2975917A priority patent/CA2975917A1/en
Priority to PCT/BR2014/000418 priority patent/WO2015117210A1/en
Publication of BR102014003033A2 publication Critical patent/BR102014003033A2/pt
Publication of BR102014003033B1 publication Critical patent/BR102014003033B1/pt
Publication of BR102014003033B8 publication Critical patent/BR102014003033B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

processo, aparato ou sistema e kit de classificação de amostras tumorais de origem desconhecida e/ou incerta e uso dos genes do grupo de biomarcadores. a presente invenção refere-se a um processo de classificação de amostras tumorais de origem primária desconhecida e/ou incerta compreendendo especialmente a etapa de obter padrões de modulação da atividade biológica de tumores de origem primária desconhecida e/ou incerta e confrontar com um conjunto específico e único de biomarcadores que determinam os perfis de modulação da atividade biológica de tumores de origem conhecida. a presente invenção se situa no campo da biologia molecular e da genética.
BR102014003033A 2014-02-07 2014-02-07 processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta BR102014003033B8 (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BR102014003033A BR102014003033B8 (pt) 2014-02-07 2014-02-07 processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta
EP14882107.7A EP3102695A4 (en) 2014-02-07 2014-11-19 Process, apparatus or system and kit for classification of tumor samples of unknown and/or uncertain origin and use of genes of the group of biomarkers
US15/117,023 US20170183738A1 (en) 2014-02-07 2014-11-19 Process, Apparatus or System and Kit for Classification of Tumor Samples of Unknown and/or Uncertain Origin and Use of Genes of the Group of Biomarkers
CA2975917A CA2975917A1 (en) 2014-02-07 2014-11-19 Process, apparatus or system and kit for classification of tumor samples of unknown and/or uncertain origin and use of genes of the group of biomarkers
PCT/BR2014/000418 WO2015117210A1 (en) 2014-02-07 2014-11-19 Process, apparatus or system and kit for classification of tumor samples of unknown and/or uncertain origin and use of genes of the group of biomarkers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102014003033A BR102014003033B8 (pt) 2014-02-07 2014-02-07 processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta

Publications (3)

Publication Number Publication Date
BR102014003033A2 BR102014003033A2 (pt) 2015-12-15
BR102014003033B1 BR102014003033B1 (pt) 2020-12-08
BR102014003033B8 true BR102014003033B8 (pt) 2020-12-22

Family

ID=53777076

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102014003033A BR102014003033B8 (pt) 2014-02-07 2014-02-07 processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta

Country Status (5)

Country Link
US (1) US20170183738A1 (pt)
EP (1) EP3102695A4 (pt)
BR (1) BR102014003033B8 (pt)
CA (1) CA2975917A1 (pt)
WO (1) WO2015117210A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105624324B (zh) * 2016-03-31 2019-06-11 北京泱深生物信息技术有限公司 垂体瘤诊治标志物
KR20210124985A (ko) * 2019-01-08 2021-10-15 캐리스 엠피아이, 아이엔씨. 유사성 게놈 프로파일링
CN111518893A (zh) * 2020-05-11 2020-08-11 深圳市人民医院 尿毒症标志物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008021115A2 (en) * 2006-08-14 2008-02-21 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
US9096906B2 (en) * 2007-03-27 2015-08-04 Rosetta Genomics Ltd. Gene expression signature for classification of tissue of origin of tumor samples
US8802599B2 (en) * 2007-03-27 2014-08-12 Rosetta Genomics, Ltd. Gene expression signature for classification of tissue of origin of tumor samples
CA2697106A1 (en) * 2007-08-28 2009-03-12 Donald Bergstrom Expression profiles of biomarker genes in notch mediated cancers
US20110230357A1 (en) * 2010-03-16 2011-09-22 Universiteit Maastricht Method for determining the primary site of cup
EP2622100A1 (en) * 2010-09-30 2013-08-07 Chipdx LLC Gene marker sets and methods for classification of cancer patients
WO2013002750A2 (en) * 2011-06-29 2013-01-03 Biotheranostics, Inc. Determining tumor origin

Also Published As

Publication number Publication date
EP3102695A4 (en) 2017-10-11
BR102014003033B1 (pt) 2020-12-08
BR102014003033A2 (pt) 2015-12-15
US20170183738A1 (en) 2017-06-29
EP3102695A1 (en) 2016-12-14
CA2975917A1 (en) 2015-08-13
WO2015117210A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
BR112018069557A2 (pt) spike-ins de ácido nucléico sintético
BR112018069849A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático
GB2568608A (en) Personalized genetic testing
EA201692157A1 (ru) Синтез двухцепочечных нуклеиновых кислот
BR112017011326A2 (pt) anticorpo, ácido nucleico, vetor, célula hospedeira, método para produzir o anticorpo, imunoconjugado, composição farmacêutica, usos do anticorpo, métodos para tratar ou retardar a progressão de distúrbio proliferativo celular e para intensificar a função imune
BR112016017155A2 (pt) Sistema e dispositivo para geração com alto rendimento de gotículas combinatoriais e métodos de uso
EA201790716A1 (ru) Использование панелей мутантных генов fgfr для выявления онкологических пациентов, которые будут поддаваться лечению ингибитором fgfr
BR112017009728A2 (pt) anticorpos isolados, ácido nucleico isolado, vetor, célula hospedeira, método para produzir o anticorpo, composição, usos de um anticorpo e métodos de tratamento de um distúrbio
EP3971299A3 (en) Colorectal cancer detection kit or device, and detection method
BR112016029521A2 (pt) ?kit, dispositivo e método para a detecção de câncer de estômago?
MX2017010836A (es) Panel biomarcador para la deteccion de cancer.
MY192493A (en) Urinalysis device and dry reagent for quantitative urinalysis
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
EA201691496A1 (ru) Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
EA201790549A1 (ru) Предиктивные и прогностические биомаркеры, связанные с антиангиогенной терапией злокачественной опухоли
BR112014028103A2 (pt) sistema e método para classificação de fácies
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
UY36200A (es) Conjunto de biomarcadores específicos para diagnóstico no invasivo de cáncer de hígado
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
EP3545314A4 (en) REAGENTS AND METHODS OF ANALYSIS OF PROTEINS AND METABOLITES TARGETED BY COVALENT PROBES
EA201990730A1 (ru) Рнк-биомаркеры для наследственного ангионевротического отека
BR112018010669A2 (pt) anticorpo anti-pcsk9 e utilização do mesmo
MX2019013953A (es) Metodo basado en expresion genica para clasificar pacientes con cancer de riñon de acuerdo al riesgo de recurrencia.
BR102014003033B8 (pt) processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR A RETRIBUICAO DA(S) 4A. ANUIDADE(S), DE ACORDO COM TABELA VIGENTE, REFERENTE A(S) GUIA(S) DE RECOLHIMENTO 0000921702021253.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/02/2014, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2605 DE 08/12/2020 QUANTO AO TITULO.